# Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting

> **NCT01474915** · PHASE4 · COMPLETED · sponsor: **Sergio Bergese** · enrollment: 122 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting (PONV)
- Nausea

## Interventions

- **DRUG:** Aprepitant
- **DRUG:** Ondansetron
- **DRUG:** Promethazine
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01474915
- **Lead sponsor:** Sergio Bergese
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2013-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01474915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01474915, "Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01474915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*